Sponsored webinar that reframed the landscape of Chemotherapy-induced myelosuppression (CIM) with a fresh perspective on the root of the clinical problem, the patient burden revealed through real world management of CIM, and the hope for a future that fulfills the unmet need – one made more complicated by the confounding influence of Covid-19 in the day-to-day management of people facing malignancy.
Sponsored webinar that provided an overview of the ATTR amyloidosis disease subtypes, pathophysiology of disease, and the varying clinical presentations, including nonspecific symptoms that should raise suspicion of and aid in diagnosis of the disease.
Sponsored webinar that discussed a new strategy for avoiding waste and improving response for highest cost therapies used in managing rheumatoid arthritis.
Sponsored webinar that reported on real-world data supporting compliance with Global Initiative for Chronic Obstructive Lung Disease (GOLD) recommendations and how it can be used to help you navigate management of your COPD population.
Despite clinical guidelines, biomarker testing is unevenly applied, leaving patients without access to targeted therapies. AMCP is engaging payers and providers to align coverage with best practices, expand real-world evidence, and reduce gaps in precision medicine adoption.